|
12P018, 10
mg/ml; 20 ml/Amp現行藥物外觀
中文名:飛可復 注射液
廠牌:FRESENIUS KABI
12P018, 10
mg/ml; 20 ml/Amp
中文名:飛可復 注射液
廠牌:FRESENIUS KABI
|
| Product
name |
|
| Dosage
form |
| 12P018,
10 mg/ml; 20 ml/Amp |
|
| Indications |
| Anesthesia, general;
ICU sedation;
Monitored anesthesia care (MAC) sedation;
Anesthesia
|
|
| Administration
& Dosage |
IV,
Adult
Anesthesia, general:
Induction,20-40 mg every 10 sec until induction onset (1-2.5 mg/kg); maintenance, 50-200μg/kg/min or 20-50 mg IV bolus; dose varies for age and surgery type.
ICU sedation:5 μg/kg/min for 5 mins then titrate to 5-50 μg/kg/min in 5-10 μg/kg/min increments; allow minimal of 5 mins between dose adjustments.
Monitored anesthesia care (MAC) sedation: initial 100-150 μg/kg/min or 0.5 mg/kg slow IV over 3-5 mins followed immediately by maintenance infusion 25-75 μg/kg/min or 10 mg or 20 mg incremental IV bolus doses.
Pediatric
Anesthesia:
Induction: 3-16 yrs, 2.5-3.5 mg/kg IV over 20-30 sec;
Maintenance: 2 mo-16 yr, 125-300 μg/kg/min. |
|
| Contraindication |
hypersensitivity to propofol products;
allergies to eggs, egg products, soybeans, or soy products. |
|
| Precaution |
|
| Adverse
reaction |
| M: Apnea; bradycardia; hypotension; involuntary muscle movements; N/V; irritancy at injection site
L or R: Hypertension; perioperative myoclonia; pancreatitis; abdominal cramping; cough; dizziness; fever; flushing; headache; hiccups; anaphylaxis; respiratory acidosis
|
|
| Drug
Interaction |
|
| Pregnancy
Category |
|
| Notes |
|
